Today, the Abortion by Fraud Criminalization Act (SB 276) passed the Louisiana Senate in a majority vote of 29-7. SB 276 creates the crime of coerced abortion by means of fraud and places the medication on Schedule IV of the Uniform Controlled Substance List. SB 276 does not prohibit the medications to be used in healthcare situations that do not result in elective abortion. Now the legislation awaits Governor Jeff Landry’s signature.
In response to the onslaught of misinformation regarding SB 276, Louisiana Right to Life is providing the following facts:
Sarah Zagorski, the Communications Director for Louisiana Right to Life said, “We are proud of Sen. Pressly’s outstanding defense of SB 276, which will protect women like his sister for decades to come. We also want to thank Senator Heather Cloud as well as Senator Jay Morris for sharing their support for SB 276.”
Zagorski added, “The intention of SB 276 is to stop the abortion industry from profiting off of abuse and trafficking of vulnerable women through their flagrantly illegal distribution of pills.”
It is evident from Sen. Pressly’s own testimony that the illegal distribution of the abortion pill is out-of-control in Louisiana, with young girls receiving the pills without parental consent, physician oversight and far past the gestational limit set forth by the Food and Drug Administration.”
Notably, not one female Senator voted against SB 278. It is important too that neither the State Medical Society nor the Louisiana Hospital Association opposed SB 276.
Sen. Pressly shared during Floor Debate the testimony of Dr. John Voltz from Lafayette highlighting the need to add abortion pills to the Uniform Controlled Substance List Schedule IV. Dr. Voltz also explains why adding the pills to Schedule IV will not result in a delay of care as abortion proponents claim. He said:
“This week, I saw a minor girl after she ordered abortion pills online. This is dangerous because there is no appropriate screening for health risks such as ectopic pregnancies. If a woman presents herself in an emergency and is bleeding, surgical intervention is necessary rather than medication such as Misoprostol. It is my opinion that placing the abortion pills in the controlled substance list will not result in a delay of care in emergencies. Healthcare providers are used to handling controlled substances on a regular basis. Rather, it will take important steps to stop a dangerous industry that threatens the health of women.”
Dr. Amber Shemwell, an OBGYN from Monroe, also shared the risks the abortion pill poses for women’s health in Louisiana:
“From my experience in Northeast Louisiana, medications such as mifepristone and misoprostol are recklessly available online and on the street without a prescription or a physician’s exam. Without proper physician screening for ectopic and molar pregnancies, these medications have the potential to be dangerous. For these reasons, I support categorizing both of these medications as controlled substances. Physicians commonly use controlled substances, and I’m confident that my care for women will not be harmed by this legislation, even as it applies to the appropriate use of misoprostol in my practice.”
Sen. Pressly was inspired to author legislation after his sister, Catherine Herring, was poisoned by her former husband with abortion-inducing drugs. He attempted to give his then-wife seven spiked drinks with the abortion pill combination, mifepristone and misoprostol. Herring’s daughter survived, however, was born 10-weeks early and attends therapy 8-times a week.
Read Louisiana Right to Life’s Investigative Report: The Rampant Abuse of Abortion Pills.